Furthermore, we analyzed the density of CD8+ sTILs and CD4+ sTILs in the NLR-CRP-high group, but no significant correlations with tumor regression were found (P=0.659 and P=0.790, respectively) (Table 4). The gene discussed is CD8A; the disease is neoplasm.